| Ytd | 43.35% | |
| 1y | 23.95% |
| Open | 22.04 | Prev Close | 21.95 | Low | 22.04 | High | 23.11 | Mkt Cap | 1.34B |
| Vol | 1.40M | Avg Vol | 1.06M | EPS | -0.23 | P/E | N/A | Forward P/E | 47.47 |
| Beta | N/A | Short Ratio | 7.90 | Inst. Own | 81.60% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 16.94 | 200-d Avg | 17.14 | 1yr Est | 22.92 |
OMDA News
Omada Health, Inc. (OMDA) witnessed a jump in share price last session on above-average trading volu
Morgan Stanley analyst Craig Hettenbach reiterates Omada Health (NASDAQ:OMDA) with a Overweight a
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises th
Citizens analyst Constantine Davides maintains Omada Health (NASDAQ:OMDA) with a Market Outperfor
Evercore ISI Group analyst Elizabeth Anderson maintains Omada Health (NASDAQ:OMDA) with a Outperf
Wells Fargo analyst Stan Berenshteyn maintains Omada Health (NASDAQ:OMDA) with a Equal-Weight and
Omada Health (NASDAQ:OMDA) announced it will serve as an independent program administrator in Eli Li
Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $312.000 million-$322.000 million to $32
Omada Health (NASDAQ:OMDA) reported quarterly losses of $(0.05) per share which beat the analyst con
Research has shown that during gradual weight loss from lifestyle interventions and older weight los
Citizens analyst Constantine Davides initiates coverage on Omada Health (NASDAQ:OMDA) with a Mark
Goldman Sachs analyst David Roman maintains Omada Health (NASDAQ:OMDA) with a Buy and lowers the
Evercore ISI Group analyst Elizabeth Anderson maintains Omada Health (NASDAQ:OMDA) with a Outperf
JP Morgan analyst Destiny Jackson maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowe
Canaccord Genuity analyst Richard Close maintains Omada Health (NASDAQ:OMDA) with a Buy and lower
BMO Capital analyst Sean Dodge maintains Omada Health (NASDAQ:OMDA) with a Outperform and lowers
Morgan Stanley analyst Craig Hettenbach maintains Omada Health (NASDAQ:OMDA) with a Overweight an
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises th
Omada Health (OMDA) shares surge after beating Q4 earnings and launching the GLP-1 Flex Care program
Omada Health (NASDAQ:OMDA) sees FY2026 sales of $312.000 million-$322.000 million vs $311.411 millio
Omada Health (NASDAQ:OMDA) reported quarterly earnings of $0.08 per share which beat the analyst con
Barclays analyst Saket Kalia maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers th
